136 related articles for article (PubMed ID: 12393023)
1. Randomized clinical trial with two doses (100 and 40 ml) of Stronger Neo-Minophagen C in Chinese patients with chronic hepatitis B.
Zhang L; Wang B
Hepatol Res; 2002 Nov; 24(3):220. PubMed ID: 12393023
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis.
Miyake K; Tango T; Ota Y; Mitamura K; Yoshiba M; Kako M; Hayashi S; Ikeda Y; Hayashida N; Iwabuchi S; Sato Y; Tomi T; Funaki N; Hashimoto N; Umeda T; Miyazaki J; Tanaka K; Endo Y; Suzuki H
J Gastroenterol Hepatol; 2002 Nov; 17(11):1198-204. PubMed ID: 12453280
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma.
Kumada H
Oncology; 2002; 62 Suppl 1():94-100. PubMed ID: 11868794
[TBL] [Abstract][Full Text] [Related]
4. The long term efficacy of glycyrrhizin in chronic hepatitis C patients.
Arase Y; Ikeda K; Murashima N; Chayama K; Tsubota A; Koida I; Suzuki Y; Saitoh S; Kobayashi M; Kumada H
Cancer; 1997 Apr; 79(8):1494-500. PubMed ID: 9118029
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis.
Iino S; Tango T; Matsushima T; Toda G; Miyake K; Hino K; Kumada H; Yasuda K; Kuroki T; Hirayama C; Suzuki H
Hepatol Res; 2001 Jan; 19(1):31-40. PubMed ID: 11137478
[TBL] [Abstract][Full Text] [Related]
6. The use of Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, in robust neuroprotection in the postischemic brain.
Kim SW; Lim CM; Lee HK; Lee JK
Anat Cell Biol; 2011 Dec; 44(4):304-13. PubMed ID: 22254159
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of Stronger Neo-Minophagen C for treatment of chronic hepatitis B: a meta-analysis of randomized controlled trials].
Chen J; Wang J; Qin T; Huang Y; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1224-9. PubMed ID: 25176104
[TBL] [Abstract][Full Text] [Related]
8. Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, protects liver against carbon tetrachloride-induced oxidative stress in transgenic mice expressing the hepatitis C virus polyprotein.
Hidaka I; Hino K; Korenaga M; Gondo T; Nishina S; Ando M; Okuda M; Sakaida I
Liver Int; 2007 Aug; 27(6):845-53. PubMed ID: 17617128
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of intravenous glycyrrhizin in the early stage of acute onset autoimmune hepatitis.
Yasui S; Fujiwara K; Tawada A; Fukuda Y; Nakano M; Yokosuka O
Dig Dis Sci; 2011 Dec; 56(12):3638-47. PubMed ID: 21681505
[TBL] [Abstract][Full Text] [Related]
10. Effects of glycyrrhizin (SNMC: Stronger Neo-Minophagen C) in hemophilia patients with HIV-1 infection.
Mori K; Sakai H; Suzuki S; Akutsu Y; Ishikawa M; Imaizumi M; Tada K; Aihara M; Sawada Y; Yokoyama M
Tohoku J Exp Med; 1990 Oct; 162(2):183-93. PubMed ID: 2129071
[TBL] [Abstract][Full Text] [Related]
11. [Effect of glycyrrhizin on anti-tuberculosis drug-induced hepatitis].
Miyazawa N; Takahashi H; Yoshiike Y; Ogura T; Watanuki Y; Sato M; Kakemizu N; Yamakawa Y; U CH; Goto H; Odagiri S
Kekkaku; 2003 Jan; 78(1):15-9. PubMed ID: 12655701
[TBL] [Abstract][Full Text] [Related]
12. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
13. Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial.
van Rossum TG; Vulto AG; Hop WC; Brouwer JT; Niesters HG; Schalm SW
J Gastroenterol Hepatol; 1999 Nov; 14(11):1093-9. PubMed ID: 10574137
[TBL] [Abstract][Full Text] [Related]
14. Quick and simple method for increasing the reduced albumin fraction in human serum albumin preparations by using stronger neo-minophagen C.
Sakata M; Kawaguchi T; Taniguchi E; Abe M; Koga H; Sata M
Hepatol Res; 2011 Nov; 41(11):1120-5. PubMed ID: 22032679
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with transfer factor and high dose stronger neo-minophagen C in chronic hepatitis B in children (HBe Ag positive).
Sumiyama K; Kobayashi M; Miyashiro E; Koike M
Acta Paediatr Jpn; 1991 Jun; 33(3):327-34. PubMed ID: 1785328
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis.
Saito Z; Kaneko Y; Kinoshita A; Kurita Y; Odashima K; Horikiri T; Yoshii Y; Seki A; Seki Y; Takeda H; Kuwano K
BMC Infect Dis; 2016 Nov; 16(1):668. PubMed ID: 27835982
[TBL] [Abstract][Full Text] [Related]
17. [Bronchial asthma due to Stronger Neo-Minophagen C].
Nakatsumi Y; Abe T; Nomura G; Fujimura M; Matsuda T
Nihon Kokyuki Gakkai Zasshi; 1998 Jul; 36(7):644-6. PubMed ID: 9805919
[TBL] [Abstract][Full Text] [Related]
18. [Effect of decoction of turtle shell for anti-fibrosis combined with stronger neo-minophagen C on indices of hepatic fibrosis in chronic hepatitis B].
Zhang L; Chang Y
Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(2):258-61. PubMed ID: 22737864
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of sequential pegylated interferon-α and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B.
Piccolo P; Lenci I; di Paolo D; Demelia L; Sorbello O; Nosotti L; Angelico M
Antivir Ther; 2013; 18(1):57-64. PubMed ID: 22872648
[TBL] [Abstract][Full Text] [Related]
20. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
